News News - 2022 Biomed start-up Hummingbird Bioscience opens new facility to boost its R&D work Continue Reading
News News - 2022 Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities Continue Reading
News News - 2022 Hummingbird Bioscience Chief Scientific Officer Jerome Boyd-Kirkup to Present at the 2nd Annual VISTA Virtual Symposium Continue Reading
News News - 2022 Hummingbird Bioscience Announces Trial in Progress Poster Presentation at the European Society for Medical Oncology Congress 2022 Continue Reading
News News - 2022 Hummingbird Bioscience to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference Continue Reading
News News - 2022 Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers Continue Reading
News News – 2021 Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies Continue Reading
News News – 2021 Hummingbird Bioscience Appoints Jan Møller Mikkelsen as Chairman of the Board Continue Reading
News News – 2021 Hummingbird Bioscience Announces Trials in Progress Poster Presentation at the Society for Immunotherapy of Cancer 2021 36th Annual Meeting Continue Reading
